EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2025 (TTM): S$0.17

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is S$0.16. In 2024 the company made an earnings per share (EPS) of S$0.17 an increase over its 2023 EPS that were of S$0.12.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2025

Annual EPS

Year	EPS	Change
2025 (TTM)	S$0.17	-1.54%
2024	S$0.17	42.43%
2023	S$0.12	8.77%
2022	S$0.11	-20.62%
2021	S$0.14	-26.59%
2020	S$0.19	27.24%
2019	S$0.15	28.41%
2018	S$0.12	20.04%
2017	S$0.09873	31.21%
2016	S$0.07524	11.46%
2015	S$0.06750	36.27%
2014	S$0.04954	19.77%
2013	S$0.04136	18.05%
2012	S$0.03504	23.9%
2011	S$0.02828	26.9%
2010	S$0.02228	12.37%
2009	S$0.01983	56.6%
2008	S$0.01266	9.18%
2007	S$0.01160	114.48%
2006	S$0.005408	64.83%
2005	S$0.003281	35.55%
2004	S$0.002421	29.73%
2003	S$0.001866	19.86%
2002	S$0.001557	-2.71%
2001	S$0.001600	1.02%
2000	S$0.001584

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions